| Issue |
Title |
| Vol 11, No 2 (2019) |
Bacteriophage MS2 As a Tool for Targeted Delivery in Solid Tumor Chemotherapy |
|
|
Kolesanova E.F., Melnikova M.V., Bolshakova T.N., Rybalkina E.Y., Sivov I.G. |
| Vol 7, No 4 (2015) |
Cancer Stem Cells: Plasticity Works against Therapy |
|
|
Vinogradova T.V., Chernov I.P., Monastyrskaya G.S., Kondratyeva L.G., Sverdlov E.D. |
| Vol 6, No 2 (2014) |
Cell Models for the Investigation of the Role of the Mucin MUC1 Extracellular Domain in Metastasizing |
|
|
Syrkina M.S., Rubtsov M.A., Potashnikova D.M., Kondratenko Y.D., Dokrunova A.A., Veiko V.P. |
| Vol 12, No 3 (2020) |
Epithelial–mesenchymal transition: role in cancer progression and the perspectives of antitumor treatment |
|
|
Gaponova A.V., Rodin S., Mazina A.A., Volchkov P.V. |
| Vol 10, No 2 (2018) |
Molecular Approaches to Safe and Controlled Engineered T-cell Therapy |
|
|
Kalinin R.S., Petukhov A.V., Knorre V.D., Maschan M.A., Stepanov A.V., Gabibov A.G. |
| Vol 7, No 2 (2015) |
Mechanisms of Oncolysis by Paramyxovirus Sendai |
|
|
Matveeva O.V., Kochneva G.V., Netesov S.V., Onikienko S.B., Chumakov P.M. |
| Vol 6, No 4 (2014) |
Human SLURP-1 and SLURP-2 Proteins Acting on Nicotinic Acetylcholine Receptors Reduce Proliferation of Human Colorectal Adenocarcinoma HT-29 Cells |
|
|
Lyukmanova E.N., Shulepko M.A., Bychkov M.L., Shenkarev Z.O., Paramonov A.S., Chugunov A.O., Arseniev A.S., Dolgikh D.A., Kirpichnikov M.P. |
| Vol 9, No 4 (2017) |
Genome Stability Maintenance in Naked Mole-Rat |
|
|
Petruseva I.O., Evdokimov A.N., Lavrik O.I. |
| Vol 7, No 2 (2015) |
Redistribution of Free- and Cell-Surface-Bound DNA in Blood of Benign and Malignant Prostate Tumor Patients |
|
|
Bryzgunova O.E., Tamkovich S.N., Cherepanova A.V., Yarmoshchuk S.V., Permyakova V.I., Anykeeva O.Y., Laktionov P.P. |
| Vol 7, No 2 (2015) |
Cancer Invasion: Patterns and Mechanisms |
|
|
Krakhmal N.V., Zavyalova M.V., Denisov E.V., Vtorushin S.V., Perelmuter V.M. |
| Vol 10, No 3 (2018) |
Expression and Intracellular Localization of Paraoxonase 2 in Different Types of Malignancies |
|
|
Shakhparonov M.I., Antipova N.V., Shender V.O., Shnaider P.V., Arapidi G.P., Pestov N.B., Pavlyukov M.S. |
| Vol 10, No 3 (2018) |
A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells |
|
|
Sapozhnikov A.M., Klinkova A.V., Shustova O.A., Grechikhina M.V., Kilyachus M.S., Stremovskiy O.A., Kovalenko E.I., Deyev S.M. |
| Vol 2, No 4 (2010) |
Hereditary Breast-Ovarian Cancer Syndrome in Russia |
|
|
Sokolenko A.P., Iyevleva A.G., Mitiushkina N.V., Suspitsin E.N., Preobrazhenskaya E.'., Kuligina E.S., Voskresenskiy D.A., Lobeiko O.S., Krylova N.Y., Gorodnova T.V., Buslov K.G., Bit-Sava E.M., Dolmatov G.D., Porhanova N.V., Polyakov I.S., Abysheva S.N., Katanugina A.S., Baholdin D.V., Yanus G.A., Togo A.V., Moiseyenko V.M., Maximov S.Y., Semiglazov V.F., Imyanitov E.N. |
| Vol 7, No 3 (2015) |
Apigenin Inhibits Growth of Breast Cancer Cells: The Role of ERα and HER2/neu |
|
|
Scherbakov A.M., Andreeva O.E. |
| Vol 8, No 3 (2016) |
Bioreactor-Based Tumor Tissue Engineering |
|
|
Guller A.E., Grebenyuk P.N., Shekhter A.B., Zvyagin A.V., Deyev S.M. |
| Vol 5, No 1 (2013) |
Overexpression of MRPS18-2 in Cancer Cell Lines Results in Appearance of Multinucleated Cells |
|
|
Shevchuk Z., Yurchenko M.Y., Darekar S.D., Holodnuka-Kholodnyuk I., Kashuba V.I., Kashuba E.V. |
| Vol 9, No 1 (2017) |
Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity |
|
|
Gerashchenko T.S., Zavyalova M.V., Denisov E.V., Krakhmal N.V., Pautova D.N., Litviakov N.V., Vtorushin S.V., Cherdyntseva N.V., Perelmuter V.M. |
| Vol 5, No 3 (2013) |
Cancer Specificity of Promoters of the Genes Involved in Cell Proliferation Control |
|
|
Kashkin K.N., Chernov I.P., Stukacheva E.A., Kopantzev E.P., Monastyrskaya G.S., Uspenskaya N.Y., Sverdlov E.D. |
| Vol 9, No 1 (2017) |
Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro |
|
|
Balalaeva I.V., Sokolova E.A., Puzhikhina A.D., Brilkina A.A., Deyev S.M. |
| Vol 9, No 1 (2017) |
Engineering Chimeric Antigen Receptors |
|
|
Kulemzin S.V., Kuznetsova V.V., Mamonkin M., Taranin A.V., Gorchakov А.A. |
| Vol 9, No 4 (2017) |
A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy |
|
|
Kalinichenko S.V., Shepelev M.V., Vikhreva P.N., Korobko I.V. |
| Vol 7, No 1 (2015) |
Interaction with Serum Albumin As a Factor of the Photodynamic Efficacy of Novel Bacteriopurpurinimide Derivatives |
|
|
Аkimova А.V., Rychkov G.N., Grin М.А., Filippova N.A., Golovina G.V., Durandin N.A., Vinogradov A.M., Коkrashvili Т.А., Mironov А.F., Shtil А.А., Кuzmin V.А. |
| Vol 12, No 3 (2020) |
GLAD-PCR assay of R(5mC)GY sites in the regulatory region of tumor-suppressor genes associated with gastric cancer |
|
|
Malyshev B.S., Netesova N.A., Smetannikova N.A., Abdurashitov M.A., Akishev A.G., Dubinin E.V., Azanov A.Z., Vihlyanov I.V., Nikitin M.K., Karpov A.B., Degtyarev S.K. |
| Vol 1, No 2 (2009) |
New Approaches for Cancer Treatment: Antitumor Drugs Based on gene-Targeted Nucleic Acids |
|
|
Patutina O.A., Mironova N.L., Vlassov V.V., Zenkova M.A. |
| Vol 2, No 4 (2010) |
Prostate Cancer Proteomics" Database |
|
|
Shishkin S.S., Kovalyov L.I., Kovalyova M.A., Lisitskaya K.V., Eremina L.S., Ivanov A.V., Gerasimov E.V., Sadykhov E.G., Ulasova N.Y., Sokolova O.S., Toropygin I.Y., Popov V.O. |
| Vol 3, No 1 (2011) |
Molecular and Physiological Mechanisms of Membrane Receptor Systems Functioning |
|
|
Severin E.S., Savvateeva M.V. |
| Vol 3, No 3 (2011) |
Transcription Factor DLX5 As a New Target for Promising Antitumor Agents |
|
|
Timakhov R.A., Fedichev P.O., Vinnik A.A., Testa J.R., Favorova O.O. |
| 1 - 27 of 27 Items |
|
